These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3110294

  • 1. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K, Chiba J, Goto Y, Tokunaga T.
    J Immunol Methods; 1987 Jun 26; 100(1-2):181-9. PubMed ID: 3110294
    [Abstract] [Full Text] [Related]

  • 2. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas.
    Karsten U, Stolley P, Walther I, Papsdorf G, Weber S, Conrad K, Pasternak L, Kopp J.
    Hybridoma; 1988 Dec 26; 7(6):627-33. PubMed ID: 3235098
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion.
    Karsten U, Papsdorf G, Roloff G, Stolley P, Abel H, Walther I, Weiss H.
    Eur J Cancer Clin Oncol; 1985 Jun 26; 21(6):733-40. PubMed ID: 2410280
    [Abstract] [Full Text] [Related]

  • 4. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
    Schmitt JJ, Zimmermann U, Neil GA.
    Hybridoma; 1989 Feb 26; 8(1):107-15. PubMed ID: 2925206
    [Abstract] [Full Text] [Related]

  • 5. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK, Perkins S, Raubitschek A, Larrick J, Lizak G, Fishwild D, Engleman EG, Grumet FC.
    J Immunol Methods; 1984 May 11; 70(1):83-90. PubMed ID: 6201562
    [Abstract] [Full Text] [Related]

  • 6. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF, Hawley RG, Hawley TS, Crawford-Sharpe GC.
    J Immunol Methods; 1992 Apr 08; 148(1-2):199-207. PubMed ID: 1373425
    [Abstract] [Full Text] [Related]

  • 7. Electrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formation.
    Li LH, Hensen ML, Zhao YL, Hui SW.
    Biophys J; 1996 Jul 08; 71(1):479-86. PubMed ID: 8804630
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
    Yu X, McGraw PA, House FS, Crowe JE.
    J Immunol Methods; 2008 Jul 31; 336(2):142-51. PubMed ID: 18514220
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
    Panova I, Gustafsson B.
    Hybridoma; 1995 Jun 31; 14(3):265-9. PubMed ID: 7590790
    [Abstract] [Full Text] [Related]

  • 12. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M, Sasamori E, Chiba T, Hanyu Y.
    J Immunol Methods; 2011 Oct 28; 373(1-2):102-10. PubMed ID: 21878337
    [Abstract] [Full Text] [Related]

  • 13. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW, Jahn S, Grunow R.
    Allerg Immunol (Leipz); 1989 Oct 28; 35(2):123-32. PubMed ID: 2788981
    [Abstract] [Full Text] [Related]

  • 14. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D, Roder JC, Chang TH, Steplewski Z, Koprowski H.
    Hybridoma; 1982 Oct 28; 1(3):323-8. PubMed ID: 6092264
    [Abstract] [Full Text] [Related]

  • 15. An extreme strategy for the production of hybridoma.
    Golestani R, Pourfathollah AA, Moazzeni SM.
    Hybridoma (Larchmt); 2009 Apr 28; 28(2):139-44. PubMed ID: 19249989
    [Abstract] [Full Text] [Related]

  • 16. The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion.
    Pratt M, Mikhalev A, Glassy MC.
    Hybridoma; 1987 Oct 28; 6(5):469-77. PubMed ID: 3500113
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H, Hirata Y, Sugawara I, Fukuda A, Yoshida TO.
    Behring Inst Mitt; 1985 Dec 28; (78):139-47. PubMed ID: 3008706
    [Abstract] [Full Text] [Related]

  • 19. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions.
    Alkan SS, Mestel F, Jiricka J, Blaser K.
    Hybridoma; 1987 Aug 28; 6(4):371-9. PubMed ID: 3623581
    [Abstract] [Full Text] [Related]

  • 20. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
    Orlik O, Altaner C.
    J Immunol Methods; 1988 Nov 25; 115(1):55-9. PubMed ID: 2848072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.